Fresenius, DE0005785604

Fresenius Stock - weekly outlook with earnings on the horizon

22.06.2026 - 11:56:32 | ad-hoc-news.de

Fresenius heads into a new trading week without fresh corporate news. For investors, the focus shifts to the upcoming earnings calendar, analyst expectations and how the healthcare group is positioned after its recent restructuring.

Fresenius, DE0005785604
Fresenius, DE0005785604

Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 11:40 CET. Details in the imprint.

Fresenius (DE0005785604) starts the new week without a fresh ad-hoc release or major rating change from the big investment banks. With no immediate news trigger, the calendar around the next quarterly figures and consensus expectations moves to the foreground for the stock.

Go deeper

All news and data on Fresenius stock

Key figures, ad-hoc disclosures and background on Fresenius are bundled in the dedicated topic area and in the company’s own investor-relations section.

What the earnings calendar shows

Fresenius has not yet published a binding date for its next quarterly statement on its investor-relations calendar, but the group typically reports half-year or Q2 figures in late July or early August according to its usual reporting pattern.

On earnings platforms, the healthcare group is often tracked via its US OTC ticker FSNUY, which helps international investors follow results and guidance in addition to the primary listing in Frankfurt.

How analysts currently view Fresenius

Consensus data compiled by market portals point to a cautiously constructive stance on Fresenius, with a mix of “Buy” and “Hold” recommendations and a moderate implied upside from current levels.

Analysts focus above all on operating performance in the remaining Fresenius businesses after the deconsolidation of Fresenius Medical Care and on deleveraging progress, which remains a central part of the equity story.

How Fresenius makes its money

Fresenius is a diversified healthcare group headquartered in Bad Homburg, Germany, active in hospital operation, infusion and nutrition therapies and related medical services.

Where the stock trades today

The shares of Fresenius (DE0005785604) last traded on Xetra at EUR 39.16 as of 06/18/2026, 17:35 CET.

Fresenius at a glance

  • Company: Fresenius SE & Co. KGaA
  • ISIN: DE0005785604
  • WKN: 578560
  • Ticker: FRE
  • Venue: Xetra
  • Price (as of 06/18/2026, 17:35 CET): 39.16 EUR
  • Market cap: 22,400,000,000 EUR (as of 06/18/2026)
  • Sector / Industry: Health Care / Health Care Providers & Services
  • Index membership: DAX
  • Next earnings date: not officially scheduled

More on Fresenius stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | DE0005785604 | FRESENIUS | boerse | 69601938 | bgmi